Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

AstraZeneca UK Limited
Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 28/03/2011
PIL Losec I.V. Injection 40mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
  • Change to date of revision
Updated on 15/03/2010 and displayed until 28/03/2011
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/03/2009 and displayed until 15/03/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to drug interactions
Updated on 15/04/2008 and displayed until 13/03/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/02/2008 and displayed until 15/04/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 31/08/2006 and displayed until 25/02/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 29/08/2006 and displayed until 31/08/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 04/08/2006 and displayed until 29/08/2006
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to date of revision
  • Change from BAN to rINN
Updated on 03/12/2004 and displayed until 04/08/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 04/09/2002 and displayed until 03/12/2004
Reasons for adding or updating:
  • Update to PIL

Active Ingredients/Generics

 
  omeprazole sodium